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BRIEF HISTORICAL OVERVIEW
Insulin’s hemodynamic actions are being
progressively unraveled over the last
two decades (Baron, 1994; Clark, 2008).
Originally, Baron et al (Laakso et al., 1990)
reported insulin-mediated increase in total
blood flow, suggesting an associated higher
delivery of nutrients and insulin to tar-
get tissues. Nonetheless, the physiological
meaning of that extensive hemodynamic
action of insulin is controversial, given
that lower insulin concentrations than
those required to increase total blood
flow, stimulate muscle glucose uptake
(Yki-Jarvinen and Utriainen, 1998; Zhang
et al., 2004). Afterward, a distinct vascu-
lar action of insulin was observed, which
resulted in capillary recruitment (Rattigan
et al., 1997). Such capillary recruitment
occurs at physiological concentrations of
insulin, precedes increases in total blood
flow and is directly correlated to glu-
cose uptake in skeletal muscle (Rattigan
et al., 1997, 1999; Coggins et al., 2001).
Provided that insulin transcapillary trans-
port plausibly involves a predominant
non-saturable process in skeletal mus-
cle (Steil et al., 1996; Hamilton-Wessler
et al., 2002; Majumdar et al., 2012),
insulin-mediated capillary recruitment
emerges as a crucial action of insulin,
coupling vascular and metabolic phys-
iology. An integrative pathophysiological
view of the relationships between hemody-
namic and metabolic functions of insulin
has been presented in detail in previous
reviews (Muniyappa et al., 2007; Clark,
2008; Muris et al., 2013). Likewise, it
has been recognized a similar vascu-
lar and metabolic insulin-signaling via
insulin receptor/phosphatidylinositol 3-
kinase (PI3K) pathways (Kim et al., 2006;
Kubota et al., 2011), which are present in
both endothelium and vascular smooth
muscle (VSM), leading to nitric oxide
synthase (NOS) activation, increased
nitric oxide (NO) production and sub-
sequent vasodilation (Zeng and Quon,
1996; Anfossi et al., 2002). Most pre-
vious research in this field has focused
on insulin actions in and/or through the
endothelium, assumed as the preponder-
ant sensor/effector organ underlying the
vascular effects of insulin (Muniyappa
et al., 2007; Kubota et al., 2011). However,
recently increased animal and human evi-
dence suggests a leading hemodynamic
role for the direct insulin action in VSM
(Rossi et al., 2005; Newman et al., 2009;
Montero et al., 2013a,c), thus requiring to





Taking the generalized view that couples
endothelial dysfunction with insulin resis-
tance (Kim et al., 2006) and considering
insulin-mediated capillary recruitment
as a rate-limiting step for glucose uptake
(Rattigan et al., 1999; Chiu et al., 2008), the
fact remains that the targeted disruption
of the insulin receptor in the endothe-
lium does not alter glucose homeostasis
(Vicent et al., 2003; Duncan et al., 2008;
Rask-Madsen et al., 2010). Conversely,
mice with endothelial cell-specific knock-
out of insulin receptor substrate 2 (IRS-2),
a signaling intermediate in the activa-
tion of PI3K, do indeed show impaired
insulin-mediated capillary recruitment
and muscle glucose uptake (Kubota et al.,
2011). Notwithstanding the lack of satis-
factory explanations for these conflicting
reports, insulin signaling in the endothe-
lium is considered to determine the access
of glucose and insulin to target tissues
(Kolka and Bergman, 2013). Yet, sev-
eral issues might be pondered before
to confirm endothelial-mediated insulin
action(s) as the crucial hemodynamic
one(s) impacting on glucose homeostasis.
First, the aforementioned study linking
vascular and metabolic impairment of
insulin action (Kubota et al., 2011)
determined IRS-2 expression in the
endothelium, adipose tissue, liver and
skeletal muscle, however, no such data
were displayed in VSM, which might be a
desirable proof of specificity of impaired
insulin- and endothelial-mediated capil-
lary recruitment. Second, allowing that
insulin signaling in the endothelium
increases NO availability, its contribu-
tion to glucose homeostasis may be, to
some extent, independent of glucose
and insulin delivery, since NOS inhibi-
tion and reduced NO levels has been
associated with ∼35% attenuation of
contraction-stimulated glucose uptake
without altering the increase in cap-
illary recruitment (Ross et al., 2007).
Third, increased, rather than decreased,
insulin signaling in the endothelium pre-
disposes to systemic insulin resistance
(Tsuchiya and Accili, 2013). Fourth,
insulin may prompt NO-independent
vasodilation through mechanisms involv-
ing the activation of potassium channels
in conduit arteries (Hasdai et al., 1998;
Izhar et al., 2000) and arterioles (McKay
and Hester, 1996; Colantuoni et al.,
2005) and removal of the endothe-
lium does not modify this response
(Hasdai et al., 1998; Izhar et al., 2000).
Furthermore, under ischemic conditions,
insulin induces arteriolar vasodilation and
capillary recruitment by the activation
of potassium channels, which subse-
quently may result in the release of NO
via increased shear stress on endothelial
cells, therein sustaining arteriolar vasodi-
lation and capillary recruitment (Bertuglia
and Colantuoni, 1998; Colantuoni et al.,
2005). Interestingly, arginine analogs com-
monly used to determine NO contribution
in vascular research, have been shown
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to inhibit potassium channel-dependent
arteriolar vasodilation (Kontos and Wei,
1996), which may cast reasonably doubt
on previous conclusions (Vincent et al.,
2003). Fifth, terminal arterioles, which
are more sensitive to insulin than larger
blood vessels (i.e., conduit and resistance
arteries, first- and second-order arterioles
(Porter et al., 1997; Oltman et al., 2000;
Zhang et al., 2004)) and are proposed to
play a decisive role in capillary recruit-
ment, do not rely on NO-dependent but
in potassium channel-dependent vasodi-
lation (McKay and Hester, 1996; Oltman
et al., 2000). Taken together, it can be
presumed that pivotal hemodynamic
actions of insulin such as capillary recruit-
ment might be mediated, primarily or
not, by physiological effectors other than
endothelial cells.
EVIDENCE OF VSM-MEDIATED
HEMODYNAMIC ACTIONS OF INSULIN
As a key physiological variable in the reg-
ulation of microvascular perfusion, the
study of vasomotion, i. e., the spontaneous
rhythmic change in arteriolar diameter,
has provided relevant insight on the hemo-
dynamic actions of insulin (Clark, 2008).
Through the analysis of the effects of vaso-
motion on perfusion oscillations, Rossi
et al (Rossi et al., 2005) discovered that
locally administered insulin specifically
increases VSM (myogenic) activity in the
skin microcirculation of healthy adults. In
contrast, De Jongh et al. (2004) reported
that, in healthy adults, hyperinsulinemia
increased intramuscular microvascular
oscillations attributed to endothelial and
neurogenic activity. The reasons for this
discrepancy are probably not related to
differences in vascular bed responsive-
ness, since there is no evidence of distinct
vascular effects of insulin in skin and mus-
cle (Meijer et al., 2012). Instead, these
equivocal findings may be explained by
differences in the expression of results. In
fact, Newman et al. (2009) found higher
myogenic activity in the muscle microvas-
culature during hyperinsulinemia when
the amplitudes of each oscillation inter-
val were normalized by the oscillatory
activity of the entire spectrum, effec-
tively taking into account differences in
the oscillatory signal strength between
experiments (Bracic and Stefanovska,
1998). Importantly, the addition of
α-methylserotonin, which is a periph-
eral vasoconstrictor that induces acute
insulin resistance by reducing capillary
recruitment without altering total blood
flow (Rattigan et al., 1999), blocked the
increased myogenic activity in response
to insulin along with decreased glucose
uptake in rat muscle (Newman et al.,
2009). Likewise, a recent report observed
decreased myogenic activity, but preserved
endothelial activity, during transdermal
insulin administration in severely obese
adolescents showing moderate hyperinsu-
linemia and insulin resistance (Montero
et al., 2013a). Moreover, multiple regres-
sion analysis determined the myogenic
activity as the primary predictor of
insulin-mediated microvascular perfu-
sion in the previous population (Montero
et al., 2013c). Collectively, the study of
vasomotion highlights the significance of
the direct action of insulin in VSM, which
if impaired, may lead to decreased insulin-
mediated capillary recruitment and hence,
less glucose and insulin availability for
target tissues.
CONCLUSIONS AND PERSPECTIVES
VSM emerges as a key player among
the hemodynamic actions of insulin. A
fine control of capillary recruitment may
be accomplished by an insulin NO-
dependent and/or –independent action
in VSM, probably in terminal arteri-
oles, which in turn regulates the intersti-
tial delivery of nutrients and hormones.
Therefore, a novel interpretation for vas-
cular insulin resistance is suggested, indi-
cating a central role for VSM dysfunction,
which has indeed been recently established
as a feature of the vascular pathology of
insulin-resistant subjects (Montero et al.,
2013b). Manipulation of insulin signaling
pathways in VSM in pathophysiologi-
cal states might thus improve vascular
and, indirectly, metabolic functions of
insulin. For that purpose, future research
should be directed at elucidating mecha-
nisms of VSM dysfunction impairing the
hemodynamic actions of insulin, which
at the moment are largely unexplored in
humans.
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